Merck & Co., Inc.
NYSEMRK heads into its next earnings cycle with options traders growing more defensive even as short sellers trim positions — a divergence that defines the week's setup. The clearest signal this week comes from options. The put/call ratio has climbed to 0.86, about one standard deviation above its 20-day mean of 0.78, and its highest reading in over a week. That's not an alarm, but it…
Snapshot as of 6 May 2026
A new long-form analysis for MRK this week — anomalies vs the company's own history, peer comparisons, news context, and the full data picture. Premium subscribers only.
Read on ORTEX →Sign up for premiumMRK heads into its next earnings cycle with options traders growing more defensive even as short sellers trim positions — a divergence that defines the week's setup. The clearest signal this week comes from options.…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for MRK — free to start on ORTEX.
